Navigation Links
MEDomics Announces a Growth Capital Investment from SpaGus Ventures LLC and Gary Augusta Joins MEDomics as Chief Operating Officer
Date:4/7/2011

AZUSA, Calif., April 7, 2011 /PRNewswire/ -- MEDomics, LLC provides NextGen sequence-based DNA diagnostic testing to enable personalized medicine in the genomics era and is transforming diagnostic testing for mitochondrial diseases.  MEDomics is proud to announce a growth capital investment from our partner, SpaGus Ventures LLC.  This second capital infusion from SpaGus will be used by MEDomics to fuel the continued growth of the company's industry leading tests for mitochondrial disease diagnosis (MitoDx and MitoNucleomeDx), that have produced over $2M in sales over a few months of limited release in the market.  In addition, Gary Augusta will become COO, join the MEDomics Board and lead the Corporate Development initiatives as the company adds senior leadership.

"We are pleased to continue and advance our relationship with SpaGus Ventures and Gary. The MitoDx and MitoNucleomeDX tests have got great traction in our target market and having Gary on board as an experienced partner further augments our senior business leadership," states Dr. Steve Sommer, Founder and President of MEDomics.

Gary Augusta states, "I am both honored and excited to invest in and work with the MEDomics team. What Dr. Sommer and the MEDomics team have accomplished is incredible and I look forward to contributing to the growth of this company and helping the patient community."

Mr. Augusta has over 20 years of experience as a CEO, CFO, growth capital investments, M&A and corporate development, angel and venture/micro private equity investing, strategy and operations management for small to Fortune 500 companies. SpaGus Ventures LLC is a fund focused on equity and debt investing for "unique" biomedical and technology companies with $1M-$10M of revenues who need capital for growth; typically for companies to "reach the next gate" of product or commercialization.  

MEDomics, LLC (www.medomics.com) is a molecular diagnostic laboratory that was founded in 2008 by Steve S. Sommer, MD, PhD, with the mission of providing Mutation Expert-based Diagnosis ("MED") to support the physician in delivering personalized medicine based on analysis of the patient's genome ("omics"). MEDomics was the first CLIA Certified Laboratory specializing in the clinical diagnostic application of Next Generation sequencing. The mutation experts at MEDomics provide quality interpretation to aid the practicing physician.  The staff at MEDomics "live and breathe" mitochondrial medicine.

Contact Information:
Jessica Thompson, Spaulding Thompson & Associates for MEDomics, LLC
949-233-8575, jessica@spauldingthompson.com

426 N. San Gabriel Ave.
Azusa, CA 91702
www.medomics.com
Phone: (626) 804-3645


'/>"/>
SOURCE MEDomics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Shionogi Announces Commercial Availability of CUVPOSA™ (Glycopyrrolate) Oral Solution for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions
2. Mtech Announces Finalists for University of Maryland $75K Business Plan Competition
3. Caliper Life Sciences Announces Date and Location of its 2011 Annual Meeting of Stockholders
4. Kimberly-Clark Health Care Announces Strategic Green Partnerships, Commitment to Reducing Medical Waste
5. Dendreon Announces Presentation of Data at the American Association of Cancer Research Annual Meeting
6. BioLife Solutions Announces Record Quarterly Revenue
7. Optimer Announces that the U.S. Food and Drug Administrations Anti-Infective Drugs Advisory Committee Voted Unanimously to Recommend Approval of Novel Antibiotic Dificid™ for Treatment of Patients with Clostridium difficile infection (CDI)
8. ResMed Announces Conference Call and Webcast to Discuss Third Quarter 2011 Results
9. Medicomp, Inc. Announces Company Purchase From United Therapeutics
10. CareFusion Announces Departure of Chief Operating Officer
11. Danaher Announces Executive Appointments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... Carolina , 12 februari 2016 /PRNewswire/ ... (AAI/CML), een toonaangevende leverancier van productie en ... biotechnologische industrieën, kondigt vandaag een uitbreiding aan ... op haar locatie in Charleston, ... heeft geleid tot meerdere recente investeringen. ...
(Date:2/11/2016)... Feb. 11, 2016 The primary goal of ... adoption patterns on the usage of liquid biopsy. Key ... - Timeframe of liquid biopsy adoption amidst ... and Evs—by organization type - Sample inflow to conduct ... saliva, stool, serum, and so on. - Correlation analysis ...
(Date:2/11/2016)... 2016  Walgreens has committed to provide drug disposal ... Washington, D.C. as part of a program ... by shareholder advocacy organization As You Sow. Conrad ... people hold on to unneeded drugs because they lack easily ... --> Conrad MacKerron , Senior Vice President ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... 12, 2016 , ... According to an article published February 4th ... significant portion of hernia repairs throughout the United States. Commenting on this article, Beverly ... that this trend has not only been expected, but it seems to be a ...
(Date:2/12/2016)... ... , ... CDRH Enforcement Trends: , Back to the Future , Feb. 25, 2016 — 11:00 ... said, “Those who don’t learn from history are doomed to repeat it.” , An analysis ... this year. But that takes time. , Take a close look at the warning ...
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... firm announced that nominations have closed for the ISE Southeast Awards 2016. Finalists ... be announced at the ISE® Southeast Executive Forum and Awards Gala on March ...
(Date:2/12/2016)... ... February 12, 2016 , ... AssureVest Insurance Group, a locally ... a charity drive that will raise funds earmarked to purchase computers and software for ... School. , “My school is in a low-income area and has more than 60 ...
(Date:2/12/2016)... ... February 12, 2016 , ... Donor Network West, the organ ... Nevada, announced a partnership with San Ramon Regional Medical Center. Under the collaboration, the ... as a way to accommodate a more certain time frame for donor families for ...
Breaking Medicine News(10 mins):